サンプル依頼リスト カート
  • English
  • Korean
表紙：心拍安定化装置の世界市場-2023年～2030年
市場調査レポート
商品コード
1345454

心拍安定化装置の世界市場-2023年～2030年

Global Beating Heart Stabilizers Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心拍安定化装置の世界市場-2023年～2030年
出版日: 2023年09月06日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

世界の心拍安定化装置市場は、2022年に2億2,120万米ドルに達し、2023-2030年の予測期間中にCAGR 5.2％で成長し、2030年には3億2,830万米ドルに達すると予測されています。外科医がより高い精度で複雑な手技を行えるようにすることを目的としたロボット支援安定化への移行などの動向は、世界の心拍安定化装置市場を独占すると予想されます。

世界の心拍安定化装置市場は近年大きく成長しており、今後も上昇傾向が続くと予測されます。市場は変革期を迎えており、画像誘導安定化、スマート安定化、適応安定化の進歩へのシフトなど、いくつかの重要な動向の影響を受けています。

さらに、心血管疾患の有病率の上昇、治療法の進歩の増加、最小侵襲処置への嗜好の高まりが、心拍安定化装置の市場規模を押し上げています。老年人口の増加や医療機器企業の存在も北米地域の需要促進要因の一つです。Terumo Cardiovascular Systems Corporation、Medtronic、Getingeなどその他の競合企業も積極的に市場に参入しています。

ダイナミクス

低侵襲手術への嗜好の高まりが心拍安定化装置市場の成長を牽引

低侵襲手術は、外傷を軽減し、回復を早め、術後の不快感を軽減する可能性があるため、低侵襲冠動脈バイパス術などの心臓治療でますます普及しています。例えば、クリーブランド・クリニックの2022年の記事によると、CABG（冠動脈バイパス術）手術は非常に一般的で、毎年約20万件の手術が行われています。より少ない切開創で安定した術野を提供する心拍安定化装置は、これらの手技をサポートする上で非常に重要です。

心拍安定化装置は、より少ない切開で安定した術野を提供することで、これらの手技を可能にする上で極めて重要です。外科医も患者も、在院日数の短縮、手術精度の向上、合併症リスクの低減が期待できるため、これらのアプローチを待ち望んでいます。その結果、予測期間中の市場を牽引しています。

心血管疾患の有病率の上昇が心臓安定剤市場の成長を促進する

冠動脈疾患や心臓弁障害などの心血管疾患の世界の有病率の上昇が、心拍安定化装置の需要急増を促進しています。例えば、米国疾病予防管理センター（Centers for Disease Control and Prevention）の2023年報告書によると、2021年には冠動脈性心疾患は375,476人の死亡につながる最も一般的な心臓病の1つです。

このような状態が外科的介入につながるほど悪化すると、適切な治療技術の必要性が不可欠になります。心拍安定化装置は、心臓の連続的な動きを抑えることで、複雑な心臓手術の間中、必要な安定性を与えるので、このような状況で重要な役割を果たします。この安定性は、手術の精度を保証し、合併症を減らす上で非常に重要です。このように、心血管疾患の有病率の増加により、市場は予測期間中に拡大すると予想されます。

心拍安定化装置の高コストが市場の成長を妨げる

心拍安定化装置の購入にかかる初期費用や維持にかかる継続的な費用などの要因により、心拍安定化装置のコストが高いことが、心拍安定化装置市場にとって大きな制約となっています。例えば、メドトロニックの組織安定装置は、標準的な心拍動下手術の場合、1台当たりおよそ559米ドルかかります。

このような経済的負担が障壁となり、多くの医療現場が、このような高度な手術装置を手術に採用することを妨げています。これらすべての要因の結果、予測期間を通じて市場は大きな制約を受けると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 低侵襲治療への嗜好の高まり
      • 心血管疾患の有病率の上昇
    • 抑制要因
      • 心拍安定化装置に関連する高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 製品タイプ別

  • 真空ベース安定化装置
  • 機械式安定化装置
  • その他

第8章 用途別

  • 冠動脈バイパス術（CABG）
  • 先天性心疾患手術
  • 心房細動手術
  • その他

第9章 エンドユーザー別

  • 病院
  • 心臓専門センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Terumo Cardiovascular Systems Corporation
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Medtronic
  • Visionary Medtech Solutions Pvt. Ltd.
  • Getinge
  • LivaNova PLC
  • Guidant Corporation
  • HTKD Medical.

第13章 付録

目次
Product Code: MD6809

Overview

Global Beating Heart Stabilizers Market reached US$ 221.2 million in 2022 and is expected to reach US$ 328.3 million by 2030 growing with a CAGR of 5.2% during the forecast period 2023-2030. The trend such as the shift towards robotic-assisted stabilization that aims in enabling surgeons to perform complex procedures with enhanced precision is expected to dominate the global beating heart stabilizers market.

The global beating heart stabilizers market has grown significantly in recent years and is projected to continue on its upward trend. The market is undergoing a transformational period, influenced by several significant trends such shift towards advancements in image-guided stabilization, and smart and adaptive stabilization.

Furthermore, the rising prevalence of cardiovascular disease, increasing advancements in treatments, growing preference for minimal invasive procedures are driving up the beating heart stabilizers market size. The growing geriatric population and presence of establish medical device companies are some of the factors in demand in the North America region. With significant competitors like Terumo Cardiovascular Systems Corporation, Medtronic, Getinge, and others actively operating in the market.

Dynamics

The Increasing Preference Towards Minimal Invasive Procedure to Drive the Growth of the Beating Heart Stabilizers Market

Minimally invasive surgical techniques are becoming increasingly prevalent in cardiac treatments such as minimally invasive coronary (heart) artery bypass due to their potential to lessen trauma, speed recovery, and reduce postoperative discomfort. For instance, according to Cleveland Clinic 2022 article, CABG (coronary artery bypass grafting) surgery is very common, with about 200,000 such procedures happening every year. Beating heart stabilizers, which provide a stable surgical field through fewer incisions, are critical in supporting these techniques.

Beating heart stabilizers are critical in allowing these procedures by delivering a stable surgical field through fewer incisions. Surgeons and patients alike look forward to these approaches because of their potential to reduce hospital stays, improve surgical precision, and reduce the risk of complications. Thereby, driving the market over the forecast period.

The Rising Prevalence of Cardiovascular Diseases will Drive the Beating Heart Stabilizers Market Growth

The rising global prevalence of cardiovascular diseases, such as coronary artery disease and heart valve disorders, is fuelling a surge in the demand for beating heart stabilizers. For instance, accroding to Centers for Disease Control and Prevention 2023 report, in 2021 coronary heart disease is one of the most common type of heart disease leading to killing of 375,476 people.

As these conditions worsen to an extent that may lead to surgical intervention, the necessity for appropriate treatment techniques becomes essential. Beating heart stabilizers play a crucial role in this situation because they give the required stability throughout complex cardiac procedures by reducing the heart's continuous motion. This stability is very important in assuring surgical precision and reducing complications. Thus, owing to the increasing prevalence of cardiovascular diseases the market is expected to drive over the forecast period.

The High Cost Associated with the Beating Heart Stabilizers Will Hamper the Growth of the Market

The high cost of beating heart stabilizers is a significant limitation for the beating heart stabilizer market, due to factors such as the initial costs of purchasing these stabilizers and the continuous costs of maintaining them, which can be fairly significant. For example, the Medtronic tissue stabilizer costs roughly $559.00 per unit for standard beating heart surgery.

This financial burden can operate as a barrier, preventing many healthcare settings from adopting these advanced surgical devices into their surgical practices. As a result of all of these factors, the market is expected to experience significant constraints throughout the forecast period.

Segment Analysis

The global beating heart stabilizers market is segmented based on product type, application, end user, and region.

Owing to the Wider Applications, the Vacuum-Based Beating Heart Stabilizers Segment Accounted for Approximately 38.4% of the Beating Heart Stabilizers Market Share

Vacuum-based beating heart stabilizers segment is expected to domiante the market. As these medical devices are used during off-pump coronary artery bypass (CABG) surgery to provide access, stability, and precision for the surgeon. These devices use vacuum suction to stabilize the target vessel or tissue on the beating heart, allowing the surgeon to perform the procedure without stopping the heart or using a heart-lung machinex

Viper I Vacuum Stabilizer is used with the Chase Medical FasTract Sternal Retractor to provide access, stability and precision for beating heart surgeries. Moreover, advancements in technologies are increasing the segment growth. For instance, in Medtronic's Octopus tissue stabilizers epicardial tissue could be stabilized using vacuum-assisted technology as standard for beating heart therapies and can be paired with cardiopulmonary bypass (CPB) to further support the patient during cardiac surgery. Thus, due to better overall application the segment is expected to dominate over the forecast period.

Geographical Penetration

North America Accounted for Approximately 39.7% of the Market Share in 2022, Owing to the Increasing Elderly Population

The growing elderly population in North America is expected to play a critical role in driving market growth. With an increasing proportion of the population reaching old age, there is a growing prevalence of cardiovascular diseases and related diseases that require medical intervention. For instance, according to Cleveland Clinic 2022 article, the average age for people to undergo coronary artery bypass grafting (CABG) surgery is around 66 years old, among which 72% of the people who undergo it are men.

Furthermore, according to United States Census Bureau 2023 report, The U.S. older population has reached 55.8 million or 16.8% and ages over 65 in 2020 and has grown five times faster than the total population over last 100 years. As the aging population needs more cardiac treatments, the demand for beating heart stabilizers, that assist in enhancing the efficacy of these surgeries, is expected to drive the region over the forecast period.

Competitive Landscape

The major global players in the beating heart stabilizers market: Terumo Cardiovascular Systems Corporation, Medtronic, Visionary Medtech Solutions Pvt. Ltd., Getinge, LivaNova PLC, Guidant Corporation, HTKD Medical, and among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a substantial influence on the healthcare business, particularly the market for beating heart stabilizers. The delaying of elective operations during the pandemic's peak decreased stabilizer demand while resuming surgeries for COVID-19-recovered patients raises concerns about changing patient profiles, increased cross-infection awareness, and a preference for less invasive treatments.

Stabilizer sterilization standards become critical, and research may target reducing inflammation and immunological responses in these people. Supply chain disruptions and a greater emphasis on patient safety shape the market even more. As cardiac procedures gradually resume, physicians and manufacturers need to collaborate together to handle the complications posed by COVID-19, assuring effective surgeries while prioritizing patient well-being.

By Product Type

  • Vacuum based Stabilizers
  • Mechanical Stabilizers
  • Others

By Application

  • Coronary Artery Bypass (CABG)
  • Congenital Heart Defect Surgeries
  • Atrial fibrillation surgery
  • Others

By End user

  • Hospitals
  • Specialty Cardiac Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

DMI Opinion

The global market for beating heart stabilizers has grown significantly and is likely to continue due to factors such as developments in cardiac surgical techniques and demand for minimally invasive procedures. The expanding prevalence of cardiovascular disorders, together with the increasing need for therapies, is driving the demand for stabilizers that allow for more precise and less invasive procedures.

Furthermore, the high cost of these devices is one of the challenges. Vacuum-based stabilizers, which provide versatility in off-pump procedures, are likely to dominate the market. Geographically, North America dominates, owing to an aging population and rising healthcare costs. Terumo Cardiovascular Systems Corporation and Medtronic are key competitors in the competitive landscape.

Why Purchase the Report?

  • To visualize the global beating heart stabilizers market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of beating heart stabilizers market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in Excel consisting of key products of all the major players.

The global beating heart stabilizers market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Preference Towards Minimal Invasive Procedure
      • 4.1.1.2. The Rising Prevalence of Cardiovascular Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. The High Cost Associated with the Beating Heart Stabilizers
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Vacuum based Stabilizers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Mechanical Stabilizers
  • 7.4. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Coronary Artery Bypass (CABG)*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Congenital Heart Defect Surgeries
  • 8.4. Atrial fibrillation surgery
  • 8.5. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Cardiac Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Terumo Cardiovascular Systems Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Medtronic
  • 12.3. Visionary Medtech Solutions Pvt. Ltd.
  • 12.4. Getinge
  • 12.5. LivaNova PLC
  • 12.6. Guidant Corporation
  • 12.7. HTKD Medical.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us